Head-to-head · WeighScore
Better U Care vs LVNG RX
The verdict
Better U Care takes it — 64.8/100 to 62.5/100.
Better U Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Better U Care is a US telehealth weight-loss practice offering compounded and brand-name GLP-1 medications with transparent self-pay pricing and no insurance required.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Better U Care | LVNG RX |
|---|---|---|
| WeighScore | 64.8/100 | 62.5/100 |
| Grade | C | C |
| Scorecard rank | #239 | #272 |
| Semaglutide | $298/mo | $149/mo (starting dose, compounded) |
| Tirzepatide | $397/mo | $249/mo (microdose tier, starting dose, compounded) |
| Coverage | 21 states | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #239 · C
Strengths
- Transparent self-pay pricing with no insurance required
- Offers both compounded and brand-name semaglutide and tirzepatide
- Uniform compounded pricing across all doses with supplies included
- Publishes its full list of covered states
Where it loses points
- Available in 21 states rather than nationwide
- Does not name a compounding pharmacy or list an accreditation seal
- Brand medications carry a separate 150 dollar consult fee
Graded #272 · C
Strengths
- One bundled price covers the provider visit, prescription, shipping and ongoing check-ins, with zero consultation charges
- States you are charged nothing if a provider does not approve you for treatment
- Promises no dose-change surcharges — 'the price we quote is the price you pay, period'
- Semaglutide from $149/mo is competitive against the wider compounded market
- Offers a lower-dose GLP-1 microdose program alongside standard semaglutide and tirzepatide
Where it loses points
- Displays a Trustpilot 'Rated Excellent 4.8 / 5' badge, but no Trustpilot profile exists for the domain or the brand
- Also claims '4.9 based on 300+ Google reviews'; no Google listing for the business could be located
- Its own homepage figures conflict — '10k+' members in the hero versus '1,743+ patients supported' in the counters below
- The actual plan price is confirmed only after provider review, and the three treatment pages publish no prices at all
- No compounding pharmacy, medical group or individual clinician is named anywhere on the site
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.